The protease inhibitor, Bowman-Birk Inhibitor, suppresses experimental autoimmune encephalomyelitis: a potential oral therapy for multiple sclerosis (Q48293570)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q42694963)
(P304) 688-697
(P433) 6
(P478) 12
(P577) Friday, December 1, 2006
(P921) (Q494066)
(Q8277)
(P1433) (Q1952449)
(P1476) "The protease inhibitor, Bowman-Birk Inhibitor, suppresses experimental autoimmune encephalomyelitis: a potential oral therapy for multiple sclerosis" (language: en)
(P2093) N Tabibzadeh
A Martin
E S Ventura
J H Ware
G X Zhang
J L Parr
A R Kennedy
A M Rostami
(P2860) (Q35623979)
(Q34308006)
(Q35781154)
(Q35176518)
(Q40437100)
(Q30680147)
(Q33665742)
(Q47624467)
(Q52507299)
(Q57253176)
(Q48416379)
(Q48267716)
(Q34264593)
(Q47739935)
(Q30670890)
(Q53484159)
(Q47581676)
(Q29618080)
(Q43743353)
(Q36171818)
(Q33688698)
(Q34803809)
(Q31097971)
(Q53527434)
(Q33210291)
(Q43629560)
(Q35891544)
other details
description scientific article

External Links